Pharma strategizes to reduce its environmental footprint while optimizing output.

Greener API Manufacturing

Reformulation strategies are useful tools for more than just stretching out return on investment.

Considering Bio/Pharma Reformulation Strategies

Amorphous solid dispersions can overcome bioavailability issues with oral oncology drugs.

Demonstrating Enhanced Capabilities of ASD Tablets

Topic

Articles

Fosun Pharma and Insilico Medicine will collaborate on AI-driven drug discovery and development of product candidates targeting multiple disease targets.

Fosun Pharma and Insilico Medicine Partner on Drug Discovery and Development Using Artificial Intelligence

The collaboration between Bristol Myers Squibb and Century Therapeutics will combine Century’s iPSC-derived allogeneic cell therapy platform with Bristol Myers Squibb’s expertise in cell therapy and oncology drug development.

Bristol Myers Squibb and Century Therapeutics to Collaborate on Developing iPSC-derived Allogeneic Cell Therapies

The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System 

FDA has cleared an IND from Poseida Therapeutics, allowing continued development of the company’s allogeneic CAR-T cell therapy candidate for treating multiple solid tumors.

FDA Accepts IND for Poseida Therapeutics’ Allogeneic CAR-T Cell Therapy Candidate

Editor of Pharmaceutical Technology Europe

Particle analysis provides assurances of the quality and performance of the final dosage form in pharmaceutical development.

Without a Particle of Doubt

Feliza Mirasol is the science editor for 

Sample preparation tends to be manually labor intensive, but automating this step helps streamline the glycosylation monitoring workflow.

Automation Helps Streamline Glycosylation Monitoring Workflow

Chris Spivey is the editorial director of 

Warp speed is amazoning pharma practices and protocols.

Industrious Pharmaceuticals

Christa Myers is a process chemical engineer for CRB.

A new focus on speed to market creates challenges for facility design and construction.

The Need for Speed: How Operation Warp Speed Shifted the Pharma Industry

Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges.

Tackling the Big Issue of Solubility

There is need for training personnel in various analytical skill sets for biologic drug substance testing.